CCB International (Shenzhen) Asset Management

CCB International (Shenzhen) Asset Management

CCB International (Shenzhen) Asset Management was established as a wholly-owned subsidiary of CCB International (Holdings) Limited, the overseas investment flagship of China Construction Bank Corporation. The firm anchors CCBI's onshore presence, originating and managing alternative assets exclusively within mainland China. While its formation date remains sparsely disclosed in English-language filings, its lineage traces directly to CCBI's broader mandate to bridge Chinese institutional capital with domestic project finance opportunities. The firm deploys primarily across real estate, infrastructure, and private credit. Real estate mandates span commercial and residential development financing, often structured as senior secured loans to developers affiliated with the parent bank's broader lending ecosystem. Infrastructure investments target China's Belt and Road-linked domestic transport and logistics assets, while the private credit book focuses on bridge financing for state-owned enterprise restructurings. A representative structure involved debt financing for urban redevelopment projects in Guangdong's Greater Bay Area, coordinated with local government investment platforms. As part of a state-controlled financial conglomerate, CCB International (Shenzhen) does not disclose standalone deployment figures or headcount. The parent group, CCB International, operates offices in Hong Kong, Singapore, and London, with the Shenzhen unit functioning as its primary onshore licensed entity for alternative asset management. In May 2024, CCB International expanded its RMB fund capabilities with a new QFLP allocation targeting healthcare infrastructure in the Greater Bay Area, underscoring the Shenzhen unit's evolving deal sourcing role. Its structural differentiator is policy proximity. Unlike independent asset managers, CCB International (Shenzhen) leverages China Construction Bank's onshore branch network and state-directed credit funnel to originate deals inaccessible to foreign GPs — a posture that doubles as both sourcing moat and regulatory constraint.